Lesion Heterogeneity and Long-Term Heteroresistance in Multidrug-Resistant Tuberculosis

J Infect Dis. 2021 Sep 1;224(5):889-893. doi: 10.1093/infdis/jiab011.

Abstract

Tuberculosis heteroresistance, in which only a fraction of the bacteria in a patient with tuberculosis contains drug-resistant mutations, has been a rising concern. However, its origins and prevalence remain elusive. Here, whole-genome sequencing was performed on 83 serial isolates from 31 patients with multidrug-resistant tuberculosis, and heteroresistance was detected in isolates from 21 patients (67.74%). Heteroresistance persisted in the host for long periods, spanning months to years, and was associated with having multiple tubercular lesions. Our findings indicate that heteroresistance is common and persistent in patients with multidrug-resistant tuberculosis and may affect the success of their treatment regimens.

Keywords: heteroresistance; multidrug- resistant tuberculosis; multiple lesions; underestimation; whole genome sequencing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antitubercular Agents / pharmacology*
  • Antitubercular Agents / therapeutic use
  • Humans
  • Microbial Sensitivity Tests
  • Mutation / drug effects
  • Mycobacterium tuberculosis / drug effects*
  • Mycobacterium tuberculosis / genetics*
  • Mycobacterium tuberculosis / isolation & purification
  • Sputum / microbiology*
  • Tuberculosis, Multidrug-Resistant / drug therapy
  • Tuberculosis, Multidrug-Resistant / genetics*
  • Whole Genome Sequencing / methods*

Substances

  • Antitubercular Agents